CH558374A - Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten. - Google Patents

Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.

Info

Publication number
CH558374A
CH558374A CH450074A CH450074A CH558374A CH 558374 A CH558374 A CH 558374A CH 450074 A CH450074 A CH 450074A CH 450074 A CH450074 A CH 450074A CH 558374 A CH558374 A CH 558374A
Authority
CH
Switzerland
Prior art keywords
chinazolone
alkenyl
aryl
derivatives
production
Prior art date
Application number
CH450074A
Other languages
German (de)
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH558374A publication Critical patent/CH558374A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH450074A 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten. CH558374A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH558374A true CH558374A (de) 1975-01-31

Family

ID=5773104

Family Applications (3)

Application Number Title Priority Date Filing Date
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH450174A CH569732A5 (OSRAM) 1970-06-05 1971-06-02

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH450174A CH569732A5 (OSRAM) 1970-06-05 1971-06-02

Country Status (10)

Country Link
US (1) US3984555A (OSRAM)
AT (3) AT318628B (OSRAM)
BE (1) BE768137A (OSRAM)
CA (1) CA951319A (OSRAM)
CH (3) CH557829A (OSRAM)
DE (1) DE2027645A1 (OSRAM)
FR (1) FR2100726B1 (OSRAM)
GB (1) GB1331522A (OSRAM)
LU (1) LU63267A1 (OSRAM)
NL (1) NL7107695A (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
EP0903344B1 (en) * 1997-08-21 2011-01-26 Shiseido Co., Ltd. Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin
US6436919B1 (en) 1999-10-01 2002-08-20 Theravance Inc. Local anesthetic compounds
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
EP2223922B1 (en) * 2000-04-25 2016-03-02 ICOS Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
EP2329822A1 (en) 2001-09-05 2011-06-08 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
CA2459584A1 (en) * 2001-09-05 2003-03-13 Cynthia C. Bamdad Compositions and use thereof in the treatment of cancer
WO2003039460A2 (en) * 2001-11-07 2003-05-15 Merck & Co., Inc. Mitotic kinesin inhibitors
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
US20060052345A1 (en) * 2002-11-04 2006-03-09 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
ATE440825T1 (de) * 2003-06-06 2009-09-15 Vertex Pharma Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
WO2005016349A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Methods of inhibiting leukocyte accumulation
US20050043239A1 (en) * 2003-08-14 2005-02-24 Jason Douangpanya Methods of inhibiting immune responses stimulated by an endogenous factor
WO2005113554A2 (en) * 2004-05-13 2005-12-01 Icos Corporation Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
WO2005117889A1 (en) * 2004-05-25 2005-12-15 Icos Corporation Methods for treating and/or preventing aberrant proliferation of hematopoietic
US20080287469A1 (en) * 2005-02-17 2008-11-20 Diacovo Thomas G Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
EP2233472B1 (en) * 2006-03-28 2014-01-15 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
SG195655A1 (en) 2008-11-13 2013-12-30 Gilead Calistoga Llc Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
AP2011005956A0 (en) * 2009-04-20 2011-10-31 Gilead Calistoga Llc Methods of treatment for solid tumors.
CA2768843A1 (en) 2009-07-21 2011-01-27 Gilead Calistoga Llc Treatment of liver disorders with pi3k inhibitors
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
EP2697206B1 (en) 2011-04-10 2019-04-03 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
PL2834241T3 (pl) 2012-03-05 2021-07-12 Gilead Calistoga Llc Formy polimorficzne (s)-2-(1-(9h-puryn-6-yloamino)propylo)-5-fluoro-3-fenylochinazolin-4(3h)-onu
WO2014009872A1 (en) 2012-07-09 2014-01-16 Lupin Limited Tetrahydroquinazolinone derivatives as parp inhibitors
JP2017500319A (ja) 2013-12-20 2017-01-05 ギリアード カリストガ エルエルシー (s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
CA2934531C (en) 2013-12-20 2020-02-25 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
WO2015191726A1 (en) 2014-06-13 2015-12-17 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053063A (OSRAM) * 1963-05-18

Also Published As

Publication number Publication date
CH557829A (de) 1975-01-15
NL7107695A (OSRAM) 1971-12-07
AT317899B (de) 1974-09-25
AT318628B (de) 1974-11-11
BE768137A (fr) 1971-12-06
AT318615B (de) 1974-11-11
DE2027645A1 (de) 1971-12-09
FR2100726A1 (OSRAM) 1972-03-24
LU63267A1 (OSRAM) 1972-08-23
GB1331522A (en) 1973-09-26
CA951319A (en) 1974-07-16
US3984555A (en) 1976-10-05
FR2100726B1 (OSRAM) 1975-10-10
CH569732A5 (OSRAM) 1975-11-28

Similar Documents

Publication Publication Date Title
CH558374A (de) Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH552607A (de) Verfahren zur herstellung von azaspiroalkandion-derivaten.
AT289065B (de) Verfahren zur Herstellung von 2,3,6-Trimethylphenol
CH547290A (de) Verfahren zur herstellung von nitro-imidazolderivaten.
CH557823A (de) Verfahren zur herstellung von piperazinderivaten.
CH550771A (de) Verfahren zur herstellung von phenaethylaminderivaten.
CH558353A (de) Verfahren zur herstellung von isoindolinderivaten.
CH550186A (de) Verfahren zur herstellung von 5-imino-1.2.4-triazin-derivaten.
CH550133A (de) Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat.
CH555801A (de) Verfahren zur herstellung von phenylaethanolamin-derivaten.
CH550797A (de) Verfahren zur herstellung von tetrahydroisochinolinderivaten.
CH551984A (de) Verfahren zur herstellung von piperazinderivaten.
CH550214A (de) Verfahren zur herstellung von cyclocopolymerisaten.
CH553185A (de) Verfahren zur herstellung von lumilysergol-derivaten.
CH549567A (de) Verfahren zur herstellung von 8-cyano-5-octanolid.
CH558800A (de) Verfahren zur herstellung von chinazolinonen.
CH547775A (de) Verfahren zur herstellung von diaethylaminopropionaniliden.
CH557830A (de) Verfahren zur herstellung von 1-aminosiochinolinen.
CH547802A (de) Verfahren zur herstellung von tetrahydropyridinderivaten.
CH550809A (de) Verfahren zur herstellung von triazol-derivaten.
CH555314A (de) Verfahren zur herstellung von cyclopropylmethylalkylaminen.
CH546782A (de) Verfahren zur herstellung von oxadiazolderivaten.
CH557801A (de) Verfahren zur herstellung von 1,1,3-trialkoxy-2-cyanopropanen.
CH537891A (de) Verfahren zur Herstellung von 2,3,6-Trimethylphenol
CH547771A (de) Verfahren zur herstellung von bornanaminderivaten.

Legal Events

Date Code Title Description
PL Patent ceased